Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by 99942Apophison Jul 02, 2023 12:57pm
234 Views
Post# 35524231

RE:RE:RE:RE:Miniature PP

RE:RE:RE:RE:Miniature PP
fecats wrote: Don't forget that there is also just over 4 million warrants at .50 for Oct 3/23 . Roger has close to a million of these . They have already been extended twice , so can't be again. Don't think he will want to lose those . But is there enough positive developments to get stock well over .50 by then ? Will also bring company about 2 million bucks . Will be interesting to see

There will be in my opinion enough positive news out by Oct 3/23 fecats as BTD should be approved and of course higher CR patient data update without question. Perhaps by October we might be told of the first of a big pharmas finalized agreement but October could still be too early for that.  As I have speculated a $3 to $5 Canadian is strongly possible by year end as Mutual Funds and large retail buyers step in.

BTD is the first milestone to be knocked down by TLT as it rolls forward,  Theralase will grow in size in my biased opinion. Proud to be a shareholder. 
<< Previous
Bullboard Posts
Next >>